Scarica l'app Stockscreener
2.96
3.50%
0.10
Dopo l'orario di chiusura:
2.73
-0.23
-7.77%
Precedente Chiudi:
$2.86
Aprire:
$3.19
Volume 24 ore:
481.36K
Relative Volume:
0.53
Capitalizzazione di mercato:
$4.35M
Reddito:
$502.40K
Utile/perdita netta:
$-7.91M
Rapporto P/E:
-0.2968
EPS:
-9.972
Flusso di cassa netto:
$-4.32M
1 W Prestazione:
+11.28%
1M Prestazione:
+24.89%
6M Prestazione:
-50.25%
1 anno Prestazione:
-82.74%
Intervallo 1D:
$2.70
$3.24
Intervallo di 1 settimana:
$2.5475
$3.67
Portata 52W:
$1.41
$35.99
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Nome
60 Degrees Pharmaceuticals Inc
Settore
Industria
Telefono
202-327-5422
Indirizzo
1025 CONNECTICUT AVENUE NW, WASHINGTON
Confronta SXTP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
2.96 | 3.92M | 502.40K | -7.91M | -4.32M | -9.972 |
|
ONC
Beone Medicines Ltd Adr
|
257.00 | 26.69B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
443.82 | 114.81B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.282 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
85.54 | 6.60B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
483.07 | 65.36B | 14.09B | 4.50B | 2.96B | 39.28 |
60 Degrees Pharmaceuticals Inc Borsa (SXTP) Ultime notizie
60 Degrees Pharmaceuticals Inc (SXTP) Has A Gold Mine On Its Hands - Stocksregister
60 Degrees Pharmaceuticals Expands Options for Malaria Prevention with Introduction of ARAKODA® (tafenoquine) 8-Count Bottle Format - mx.advfn.com
SXTP60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split - mx.advfn.com
Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health - mx.advfn.com
60 Degrees Pharmaceuticals introduces new malaria drug packaging By Investing.com - Investing.com Canada
Moleculin Reports Positive Topline Efficacy Results from U.S. Phase 1B/2 Clinical Trial Evaluating Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases (MB-107) - The Manila Times
60 Degrees Pharmaceuticals Expands Options for Malaria Prevention with Introduction of ARAKODA® (tafenoquine) 8-Count Bottle Format - GlobeNewswire Inc.
60 Degrees announces results from an insurance claims analysis on babesiosis - Yahoo Finance
60 Degrees Pharmaceuticals (SXTP) Reveals New Insights on Babesi - GuruFocus
60 Degrees Pharmaceuticals (SXTP) Reveals New Insights on Babesiosis and Chronic Fatigue | SXTP Stock News - GuruFocus
Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals - Yahoo Finance
Gulf Keystone Petroleum (OTCMKTS:GUKYF) Trading 5.9% Higher – Should You Buy? - Defense World
PROG Holdings, Inc. (NYSE:PRG) Short Interest Update - Defense World
Mobileye Global Inc. (NASDAQ:MBLY) Given Consensus Rating of “Hold” by Analysts - Defense World
Polar Power, Inc. (NASDAQ:POLA) Sees Significant Decline in Short Interest - Defense World
Woodside Energy Group Ltd (NYSE:WDS) Given Consensus Recommendation of “Hold” by Analysts - Defense World
Goldmoney (OTCMKTS:XAUMF) Shares Up 0.6% – Still a Buy? - Defense World
FTI Foodtech International (CVE:FTI) Stock Price Up 2.3% – Still a Buy? - Defense World
Stelco (OTCMKTS:STZHF) Shares Up 1.1% – What’s Next? - Defense World
Trevi Therapeutics (NASDAQ:TRVI) Given “Buy” Rating at D. Boral Capital - Defense World
Cardiol Therapeutics (NASDAQ:CRDL) Now Covered by Analysts at HC Wainwright - Defense World
iShares ESG Aware MSCI EM ETF (NASDAQ:ESGE) Short Interest Update - Defense World
Southwest Gas Holdings, Inc. (NYSE:SWX) Sees Large Increase in Short Interest - Defense World
Muscle Maker (NASDAQ:GRIL) Trading Down 4.2% – What’s Next? - Defense World
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Price Target Raised to $7.00 at Ascendiant Capital Markets - Defense World
CIIG Merger (OTCMKTS:CIICU) Trading Down 5.1% – Here’s What Happened - Defense World
Kidoz (CVE:KIDZ) Trading 2.9% Higher – Should You Buy? - Defense World
Ascendiant Capital lowers 60 Degrees stock price target to $7 By Investing.com - Investing.com India
Ascendiant Capital Raises Price Target for SXTP to $7.00 | SXTP Stock News - GuruFocus
Ascendiant Capital lowers 60 Degrees stock price target to $7 - Investing.com
Ulta Beauty (NASDAQ:ULTA) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
Uber Technologies, Inc. (NYSE:UBER) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
4D Molecular Therapeutics (NASDAQ:FDMT) Receives Sell (E+) Rating from Weiss Ratings - Defense World
Research Analysts’ Recent Ratings Changes for Adaptimmune Therapeutics (ADAP) - Defense World
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given Sell (E+) Rating at Weiss Ratings - Defense World
Lazard Asset Management LLC Acquires New Position in FARO Technologies, Inc. (NASDAQ:FARO) - Defense World
Live Radar: Track thunderstorms as they move across Southeast Georgia and Northeast Florida (Video) - Spot On Florida
Cetera Investment Advisers Has $876,000 Stock Holdings in Goldman Sachs BDC, Inc. (NYSE:GSBD) - Defense World
Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews
VSee Health Launches AI-Powered Telehealth to Reduce Maternal Deaths in Remote Philippines - Quantisnow
Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation - The Manila Times
60 Degrees Pharmaceuticals, Inc. Reports 55% Increase in Q1 2025 Net Product Revenues to $163.6 Thousand - Nasdaq
60 Degrees Pharmaceuticals Announces First Quarter 2025 Results - The Globe and Mail
60 DEGREES PHARMACEUTICALS, INC. SEC 10-Q Report - TradingView
60 Degrees Pharmaceuticals (SXTP) to Release Quarterly Earnings on Wednesday - Defense World
KORE Group (KORE) to Release Quarterly Earnings on Thursday - Defense World
SPAR Group (SGRP) Expected to Announce Earnings on Wednesday - Defense World
Society Pass (SOPA) Projected to Post Quarterly Earnings on Wednesday - Defense World
Windtree Therapeutics (WINT) to Release Earnings on Wednesday - Defense World
Spero Therapeutics (SPRO) to Release Earnings on Wednesday - Defense World
60 Degrees Pharmaceuticals’ (SXTP) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - Defense World
60 Degrees Pharmaceuticals Inc Azioni (SXTP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
60 Degrees Pharmaceuticals Inc Azioni (SXTP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
| XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
| DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
| DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
| DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
| DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
| DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
| DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
| XU CHERYL | Director |
Aug 27 '24 |
Buy |
1.70 |
5,000 |
8,500 |
41,078 |
0.86%
1.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):